Article
β-catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinoma.
Oncology - 1 Jan 2014
Lu Li-Chun, Shao Yu-Yun, Lee Yi-Hsuan, Hsieh Min-Shu, Hsiao Chi-Huang, Lin Hsiao-Hui, Kao Hsiang-Fong, Ma Yu-Yi, Yen Feng-Chu, Cheng Ann-Lii, Hsu Chih-Hung
Abstract excerpt
OBJECTIVES: Mutation of the exon 3 of CTNNB1, the coding gene of β-catenin, is a crucial molecular mechanism leading to aberrant activation of the Wnt/β-catenin pathway, which is highly associated with the carcinogenesis of hepatocellular carcinoma (HCC). The prevalence and clinical significance of CTNNB1 mutations in advanced HCC remain unclear. METHODS: Patients with advanced HCC and available pathologic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
